The Australian government announced last week there's a new vaccine for pneumococcal disease on the National Immunization Program for all children. This vaccine replaces previously listed pneumococcal ...
Pneumococcal vaccines are the most effective way to protect yourself or your child against pneumococcal disease, and may help prevent infections including ear infections, pneumonia (lung infection), ...
What Is It, and Why Does It Matter? Capvaxive is a 21-valent pneumococcal conjugate vaccine (PCV21). It trains your immune system to recognize 21 types of Streptococcus pneumoniae, a germ that can ...
The Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia. An ...
The increase in invasive pneumococcal disease across Europe is driven by Streptococcus pneumoniae, which also causes pneumonia and acute otitis media that can progress to invasive infections. Nearly ...
Add Yahoo as a preferred source to see more of our stories on Google. Are you at least 50 years old? The Center for Disease Control (CDC) now recommends you get vaccinated against pneumococcal ...
—Among adults, coverage and preventable burdens were lowest for pneumococcal conjugate vaccine (PCV) 15 and highest for PCV31, with PCV21 preventing notable burdens of both acute respiratory ...
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from STRIDE-8, a Phase 3 trial evaluating CAPVAXIVE™ (Pneumococcal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results